Nervgen Pharma (NGEN) Price to Book (2024 - 2026)

Nervgen Pharma's (NGEN) quarterly Price to Book came in at 13.14 in Q2 2026, down 82.32% quarter-over-quarter from 74.31 in Q1 2026.

Analysis

Nervgen Pharma (NGEN) Price to Book (2024 - 2026) Analysis & Trends

Nervgen Pharma (NGEN) has reported Price to Book for 3 consecutive years, with 13.14 the latest figure, recorded in Q2 2026.

On a quarterly basis, Price to Book changed N/A year-over-year to 13.14 in Q2 2026; TTM through Jun 2026 was 13.14, a N/A change from a year earlier, with the FY2025 full-year figure at 178.9, up 119.58% from the prior year.
Price to Book was 13.14 for Q2 2026 at Nervgen Pharma, down from 74.31 in the prior quarter.
Over five years, Price to Book peaked at 178.9 in Q4 2025 and troughed at 13.14 in Q2 2026.
A 3-year average of 87.37 and a median of 78.72 in 2024 frame the typical range for Price to Book.
The widest YoY moves for Price to Book: up 115.21% in 2025, down 115.21% in 2025.
Over 3 years, Price to Book stood at 83.13 in 2024, then jumped by 115.21% to 178.9 in 2025, then sank by 92.66% to 13.14 in 2026.
The last three Price to Book figures came in at 13.14 (Q2 2026), 74.31 (Q1 2026), and 178.9 (Q4 2025), per Business Quant data.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Amgen	236.37 Bn	222.38 Bn	7.24 Bn
2	Gilead Sciences	187.38 Bn	184.12 Bn	6.22 Bn
3	Vertex Pharmaceuticals	138.36 Bn	130.51 Bn	2.84 Bn
4	Regeneron Pharmaceuticals	85.09 Bn	77.10 Bn	3.93 Bn
5	Argenx Se	63.93 Bn	58.75 Bn	1.37 Bn
6	Moderna	58.07 Bn	52.94 Bn	52.00 Mn
7	Alnylam Pharmaceuticals	35.59 Bn	32.28 Bn	992.69 Mn
8	Biogen	32.63 Bn	31.34 Bn	1.96 Bn
9	Insmed	27.57 Bn	26.41 Bn	358.27 Mn
10	Nervgen Pharma	185.58 Mn	185.58 Mn	-

Historic Data

Download Data